Patent ID: 11919851
Assignee: KETOLIPIX THERAPEUTICS GMBH
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 12:
13. A pharmaceutical composition,
wherein the pharmaceutical composition comprises at least one a polyol ester corresponding to the general formula (IIIb)

R2O—CH2—CH(OR2)—CH2—[O—CH2—CH(OR2)—CH2]p—OR2  (IIIb)

wherein, in the general formula (IIIb),
the variable p represents an integer from 1 to 4,
R2, independently of each other, represents: hydrogen, a radical CH3—CH(OH)—CH2—C(O)— or a radical CH3—CH(OR1)—CH2—C(O)— with R1=acyl group selected from an acetyl group of formula —C(O)—CH3) and a propionyl group of formula —C(O)—C2H5, however, with the proviso that at least one radical R2 represents a radical CH3—CH(OH)—CH2—C(O)— or a radical CH3—CH(OR1)—CH2—C(O)— with R1 as defined hereinabove.